Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease

Supervised exercise therapy (SET) is the recommended first treatment for patients with leg artery disease (peripheral arterial disease, PAD) causing pain when walking. However, approximately 40% of patients do not benefit meaningfully and go on to require a procedure to open the blocked arteries within three months. This study investigates whether body composition measurements - specifically the quality of muscle and the amount of belly fat - taken from a CT scan already performed as part of routine care, can identify before treatment begins which patients are unlikely to respond to exercise therapy. If confirmed, this approach would allow doctors to use information from a scan patients are already having, with no additional tests, to better match patients to the right treatment from the start.

Participants needed: 128
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Nemocnice AGEL Trinec-Podlesi a.s.Updated: Feb 25, 2026
Eligibility criteria

Age 18 years or older [+5]

Fontaine stage III or IV peripheral arterial disease (rest pain or tissue loss;... [+5]

Status: Recruiting

Mixed Reality in MitraClip Implantation: Preliminary Case Series

The study aims to evaluate the impact of mixed reality (MR) technology, particularly using Hololens 2.0 and specialized software for three-dimensional DICOM image visualization, on MitraClip implantation procedures. This preliminary case series includes a comparative analysis of four MitraClip implantations, assessing procedural efficiency, radiation exposure, and operator stress through both physiological and subjective measures.

Participants needed: 14
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Nemocnice AGEL Trinec-Podlesi a.s.Updated: Jan 13, 2025Locations: 1Duration: 6 Months
Eligibility criteria

Adults aged over 18 years [+2]

Patients with contraindications for MR technology (e.g., MRI incompatibility) [+2]